October 17, 2024

Immorta Bio CEO Featured in Empowered Patient Podcast

Driving Longevity and Treating Diseases of Aging Using Cellular Rejuvenation with Dr. Boris Reznik

Immorta Bio CEO joins the Empowered Patient Podcast with Karen Jagoda to discuss the company’s mission to fight diseases of aging using the power of stem cell rejuvenation and senolytic immunotherapy. Boris explains the company's founding with his business partner, Dr. Thomas Ichim, as they witnessed the rapid advancement in longevity technologies that paved the way for “radical life extension” opportunities. Since then, Immorta Bio has been dedicated to developing innovative, scientifically-based cellular therapies designed to restore vitality to aging patients.

“For the first time in human history, we have a realistic chance at radical life extension”

Notable Points In the Podcast:

0:36 – 3:40 Origins of Immorta Bio and its mission

3:50 – 9:21 Immorta Bio technologies: SenoVax™ and Stem Cell Revivify™

9:30 –13:40 Discussion of the autologous (patient-specific) treatment approach

14:00 – 18:45 Initial focus studies / preclinical programs

19:10 – 21:44 The benefit of “young” stem cells

21:51 – 23:11 Mission-driven goals

Full Podcast:

Empowered Patient Podcast

Follow Immorta Bio

LinkedIn

X

Explore More

November 20, 2024

Nature Publication Supports Senolytic Approach for Cancer Treatment

November 3, 2024

Immorta CSO Featured in BioFuture 2024 Longevity Panel

October 29, 2024

Immorta Bio's SenoVax™ Reduces Growth and Stops Metastasis of Aggressive Breast Cancer Using its First-In-Class Immune Stimulatory Therapy

See all news
Join our newsletter to stay up to date on features and releases
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
By subscribing, you are acknowledging your consent to receive  Immorta Bio newsletters
19505 Biscayne Blvd, Ste 2350 Aventura, Florida 33180
305 632-2939
info@immortabio.com